C5AR2 and breast carcinoma: A study compared CAFs from chemoresistant breast cancer biopsies and CAFs from chemosensitive before neoadjuvant chemotherapy, and identified that cell-surface markers CD10 and G protein-coupled receptor 77 (GPR77) are upregulated in the CAFs from chemoresistant tumors [45].